RANK Ligand Inhibitor
5 drugs across 2 manufacturers|0 Generic,5 Brand
Total Drugs
5
0G / 5B
Manufacturers
2
Avg $1853.4507/unit
Avg 7d Change
+0.03%
Across 1 drugs with changes
7d Activity
1↑4 flat
of 5 total drugs
Class Price Trend
Monthly average NADAC price per unit, split by generic and brand
Manufacturer Breakdown
2 manufacturers producing drugs in this therapeutic class
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
XGEVA 120 MG/1.7 ML VIAL denosumab | $2001.5168 per ML | — |
XGEVA 120 MG/1.7 ML VIAL denosumab | $2001.5168 per ML | — |
PROLIA 60 MG/ML SYRINGE denosumab | $1863.9510 per ML | — |
PROLIA 60 MG/ML SYRINGE denosumab | $1863.9510 per ML | — |
JUBBONTI 60 MG/ML SYRINGE denosumab | $1536.3181 per ML | +0.03% |